Nocturna Therapeutics
noctuRNA Therapeutics is a spin-off from Universitat Pompeu Fabra. noctuRNA Tx has built a patented RNA-based drug platform that enables the generation of novel candidate therapeutical molecules within 2 to 4 weeks. This drug platform is based on artificial circular RNA molecules (circRNA) that efficiently disrupt pathogenic or aberrant RNA secondary structures present in several diseases. We have developed a first-in-class therapeutic approach to tackle some of the world's most intractable diseases.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Nocturna Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
Showing 1 of 6 verified contacts
Top roles at Nocturna Therapeutics
6 distinct titles indexed · top 6 shown.
- 1bioinformatics scientist
- 1ceo
- 1chief sales officer (cso)
- 1chief scientific officer
- 1cofounder and vp of research
- 1scientist
Sign up to unlock all 6 contacts at Nocturna Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Nocturna Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.